Soliman, Karima Nasraldin, Ingy M
The metabolic improvements associated with weight lossreduced insulin resistance, decreased inflammation, and improved lipid profilesall contribute to hormonal rebalancing that may temporarily disrupt established (albeit irregular) menstrual patterns before ultimately improving cycle regularity in many cases
GLP-1 medications slow gastric emptying and reduce appetite, which can lower daily fiber intake and alter the gut microbiome
Novo Nordisk (2026) Wegovy pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class
Weight loss associated with semaglutide use is linked to improved reproductive measures in PMOS: a proof-of-concept analysis
J., Al-Sabah, S., de Maturana, R